Filter Results :

Your search for Antibodies returned 58 reports

Sort by


Global Breast Cancer Monoclonal Antibodies Market Outlook 2020

22 May 2015  |  Published by:  KuicK Research
Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and eff...

$ 1,800.00

Read More

The 2016 Report on AntiCD20 Monoclonal Antibodies: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

01 Apr 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of A...

$ 1,439.30

Read More

Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux

28 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015. Purchase of the downloa...

$ 276.79

Read More

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

25 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated malignancies and rheumatoid arthritis as of March 2015. Purchase of...

$ 332.15

Read More

Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020

24 Mar 2015  |  Published by:  MarketsandMarkets
Report Description Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions. The report segments the global protein engineering market product, technology, pr...

$ 4,650.00

Read More

Competitor Analysis: TNF Antibodies 2015 - Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

22 Mar 2015  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence report about TNF Antibodies 2015 – Biosimilars and Biosuperiors of Humira, Remicade and Enbrel provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha or its receptor used to treat various inflamma...

$ 553.58

Read More

Global Monoclonal Antibodies Pipeline Insight 2015

04 Mar 2015  |  Published by:  PNS Pharma
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with ...

$ 2,400.00

Read More

Competitor Analysis: Specific and Bispecific Her3 Antibodies

16 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Specific and Bispecific Her3 Antibodies provides a competitor evaluation in the field of recombinant specific antibodies targeting Her3 or bispecific antibodies targeting Her3 and Her2 or EGF-R or other targets for treatment of cancer as of February 2...

$ 221.43

Read More

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

15 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downl...

$ 332.15

Read More

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis

08 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a competitor evaluation in the field of recombinant antibodies targeting vascular endothelial growth factor (VEGF) or its receptors (VEGF-R) used to treat ...

$ 387.50

Read More

Monoclonal Antibodies Partnering Terms and Agreements

01 Feb 2015  |  Published by:  CurrentPartnering
The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deal...

$ 2,995.00

Read More

Global Markets for Research Antibodies

01 Jan 2015  |  Published by:  BCC Research
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019. This report provides:-An overview of the globa...

$ 6,650.00

Read More

Fusion Antibodies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

18 Nov 2014  |  Published by:  GlobalData
SummaryFusion Antibodies Ltd (Fusion Antibodies) is a contract research organization (CRO). It holds expertise and offers contract services in the production of monoclonal antibodies, antibody sequencing, antibody engineering and humanization, and antibody expression. The organization offers a wide ...

$ 250.00

Read More

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

03 Nov 2014  |  Published by:  MarketsandMarkets
Report Description Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The mono...

$ 4,650.00

Read More
Total 58 records.